Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 410M
17.15x1.95x-2.03x3.68x9.49x10.99x0.6% 66.25B
26.07x3.94x1.89x5.39x15.85x19.65x0.6% 52.86B
33.98x6.82x0.66x11.48x21.98x25.6x-.--% 43.01B
-44.33x2.45x0.34x3.15x9.3x10.85x3.45% 39.52B
24.04x1.57x-3.74x3.43x11.65x13.51x-.--% 29.19B
55.87x3.3x-0.83x3.21x26.87x27.24x-.--% 23.13B
-6.71x4.07x-0.35x9.37x-5.77x-5.4x-.--% 23.04B
66.64x5.99x0.43x6.57x45.21x51x-.--% 20.48B
24.35x3.57x0.02x5.21x13.64x18.86x-.--% 16.6B
-37.32x-6.59x0.9x17.71x-48.48x-56.03x-.--% 16.2B
-116.24x12691.74x2.64x12.48x-89.37x-124.56x-.--% 12.33B
17.31x - 0.2x3.56x13.78x16.09x-.--% 11.29B
45.1x - 4.91x - - - -.--% 9.93B
49.03x19.99x0.46x29.56x41.81x43.12x0.19% 9.72B
12.85x1.15x0.45x1.86x7.49x10.13x2.66% 6.74B
29.13x - 1.43x7.85x20.82x24.86x0.35% 5.95B
-46.55x - -0.84x - - - - 5.87B
60.96x4.31x-0.78x - - - - 5.79B
13.95x1.26x-0.2x2.39x6.25x7.55x1.64% 5.51B
Average 11.86x 849.70x 0.29x 7.93x 6.28x 5.84x 0.56% 20.19B
Weighted average by Cap. 13.22x 425.91x -0.04x 6.81x 9.54x 10.39x 0.61%
Biopharmaceuticals